| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCZ-110 | L-Asparagine | >98%,Standard References |
|
| DCS-100 | L-Threonine | >98%,Standard References |
|
| DCW-031 | Pseudoprotodioscin | >98%,Standard References |
|
| DCC-039 | Polyphyllin VII | >98%,Standard References |
|
| DCS-124 | Jujuboside B1 | >98%,Standard References |
|
| DCS-046 | Jujuboside B | >98%,Standard References |
|
| DCQ-047 | Deapio-platycodin D | >98%,Standard References |
|
| DCJ-004 | Gypenoside XLIX | >98%,Standard References |
|
| DCJ-039 | Methylprotodioscin | >98%,Standard References |
|
| DCC-072 | Hederacoside D | >98%,Standard References |
|
| DCC-005 | dipsacoside B | >98%,Standard References |
|
| DCG-040 | Polygalasaponin F | Polygalasaponin F, an oleanane-type triterpenoid saponin extracted from Polygala japonica, decreases the release of the inflammatory cytokine tumor necrosis factor a (TNFa). Polygalasaponin F reduces neuroinflammatory cytokine secretion through the regulation of the TLR4-PI3K/AKT-NF-kB signaling pathway . |
|
| DCR-014 | Ginsenoside Rb3 | >98%,Standard References |
|
| DCR-008 | Ginsenoside Rc | >98%,Standard References |
|
| DCR-013 | GINSENOSIDE RB2 | >98%,Standard References |
|
| DCL-029 | Araloside V | >98%,Standard References |
|
| DCL-030 | Araloside VII | >98%,Standard References |
|
| DCR-012 | Ginsenoside Rb1 | >98%,Standard References |
|
| DCQ-038 | Sodium Aescinate | >98%,Standard References |
|
| DCQ-063 | Aescin IA | >98%,Standard References |
|
| DCG-043 | Triolein Featured | Triolein is a symmetric triacylglycerol that reduces upregulation of MMP-1 and has strong antioxidant and anti-inflammatory activities. |
|
| DCJ-013 | Platycodin D | >98%,Standard References |
|
| DCS-045 | Jujuboside A | >98%,Standard References |
|
| DCS-123 | Jujuboside D；Jujuboside A1 | >98%,Standard References |
|
| DCP-005 | Ubidecarenone | >98%,Standard References |
|
| DCC-041 | Hederasaponin B | >98%,Standard References |
|
| DCB-029 | Anemoside B4 Featured | Pulchinenoside B4 is a triterpenoid glycoside that inhibits cisplatin-induced apoptosis, increases in reactive oxygen species (ROS) production, and decreases in superoxide dismutase (SOD) and catalase activities. Pulchinenoside B4 also prevents increases in plasma blood urea nitrogen (BUN) and creatinine levels -- markers of kidney injury. |
|
| DCH-074 | Macranthoidin A | >98%,Standard References |
|
| DCG-052 | L-Glutamine | >98%,Standard References |
|
| DCZ-159 | DL-Arabinose | >98%,Standard References |
|
